FDA approves Boehringer Ingelheim COPD treatment
RIDGEFIELD, Conn. — The Food and Drug Administration has approved a new product for chronic obstructive pulmonary disease made by Boehringer Ingelheim Pharmaceuticals, the drug maker said.
The company announced the approval of Combivent Respimat (ipratropium bromide and albuterol sulfate), delivered in a propellant-free inhaler that uses a slow-moving mist to deliver the same active ingredients as the Combivent Inhalation Aerosol. The new product is expected to become available in mid 2012, BI said.
"Combivent Respimat is a testament to our company’s dedication and focus on making meaningful developments in respiratory medicine," Boehringer Ingelheim Pharmaceuticals president and CEO Greg Behar said. "Leveraging our extensive respiratory therapeutic experience and a long history of bringing innovative medicines to patents, we continue to expand our strong clinical program examining the potential of several late-stage investigational compounds also delivered by the Respimat inhaler."
Milan Puskar, co-founder of Mylan, dies
PITTSBURGH — Mylan co-founder and former chairman and CEO Milan "Mike" Puskar died Saturday, the generic drug maker said. Puskar, who retired from Mylan as chairman in 2009, was 77.
"We were deeply saddened by the passing of Mike Puskar, a truly one-of-a-kind individual," Mylan chairman and CEO Robert Coury said. "Mike was a pioneer in many ways and helped to create the generics industry as we know it today. Those of us who knew Mike personally will always remember him as a strong leader, thoughtful mentor, generous benefactor and faithful friend."
Puskar, a former U.S. Army soldier, and fellow soldier Don Panoz formed Mylan in West Virginia in 1961, according to the company. Mylan originally was a distributor that bought finished goods and sold them to pharmacies and doctors, but won Food and Drug Administration approval to manufacture Penicillin G in 1966. In 2007, under Coury’s leadership, Mylan bought a majority stake in India’s Matrix Labs, thus making Mylan a global company. Since then, it has become the world’s third-largest generic drug maker, and the largest in the United States.
"Mr. Puskar was a principal figure in the development of the modern generic industry, an extraordinary thought leader in the pharmaceutical community and a kind and generous individual whose innumerable charitable contributions continue to improve lives across our society," a statement by the Generic Pharmaceutical Association read. "His tireless efforts to ensure the highest quality in all facets of the generic drug business have set a standard in industry that will have a lasting impact for years to come."
Derma e Natural Bodycare hires Canadian regional sales manager
SIMI VALLEY, Calif. — Derma e Natural Bodycare has hired Kathleen Dills as Canadian regional sales manager.
With Canada as the second-largest market for derma e products, the new role was created to help support and grow the company’s North American business, the company stated.
Dills comes to derma e with 17 years of experience in the natural products industry. Previously, Dills worked as the director of vendor relations and marketing for Purity Life Health Products, Canada’s largest natural health products supplier.
In the new position, Dills will be responsible for the sales of derma e’s 90-plus anti-aging and natural body care products throughout Canada. This includes territory development, account management and execution of tactical programs to grow new and maintain existing business. The position also will focus on trainings and education of the derma e brand.